Actinium Pharmaceuticals, Inc.

Ownership Transactions Reported by 7 Insiders

Symbol
ATNM on NYSE
Industry
Pharmaceutical Preparations
Location
100 Park Ave., 23 Rd Floor, New York, New York

There are no Buy or Sell transactions made by insiders since 7/6/2023

Actinium Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ajit Shetty Director Dec 28, 2023
Richard Steinhart Director Dec 28, 2023
C. David Nicholson Director Dec 28, 2023
Sandesh Seth Chief Executive Officer, Director Dec 28, 2023
Steve O'Loughlin Chief Financial Officer Dec 28, 2023
Mark Berger Chief Medical Officer Sep 1, 2021
Jeffrey W. Chell Director Dec 28, 2023

Recent Insider Transactions by Companies or Individuals for Actinium Pharmaceuticals, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership